Cure8
Evaluation of capsule endoscopy and fecal calprotectin for risk stratification in asymptomatic Crohn’s disease: a prospective observational study
BMC Gastroenterology

Cure8 research brief

Evaluation of capsule endoscopy and fecal calprotectin for risk stratification in asymptomatic Crohn’s disease: a prospective observational study

1 min read
Tests and monitoring Capsule Endoscopy Fecal calprotectin Clinical study Adult patients Clinicians Patients On Biologics Newly Diagnosed
Limited source text

What Cure8 can confirm

What We Know

Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, Capsule Endoscopy, and Fecal calprotectin. Use the original source link for the full details.

What Is Not Available

The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationBMC Gastroenterology
PublisherSpringer Science and Business Media LLC
AuthorsNobuhiro Ueno, Tsubasa Onoda, Ryunosuke Hayashi +11 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedSep 22, 2026, 12:00 AM
Content availableMetadata only

Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.

Related Reading

Browse latest news →